Hanmi Pharm. Co.

128940.KO

185.29 USD

-1.47

-0.79%

Overview

Last close

185.29 usd

Market cap

2.35B usd

52 week high

279.68 usd

52 week low

185.29 usd

Target price

281.66 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

2.1258

Price/Book Value

3.1077

Enterprise Value

2.58B usd

EV/Revenue

2.3358

EV/EBITDA

10.4692

Key financials

Revenue TTM

1.11B usd

Gross Profit TTM

506.23M usd

EBITDA TTM

256.61M usd

Earnings per Share

N/A usd

Dividend

0.53 usd

Total assets

1,975.73B usd

Net debt

N/A usd

About

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.